MIR548AR: A Potential Drug Target and Biomarker (G100847035)
MIR548AR: A Potential Drug Target and Biomarker
MIR548AR, a protein encoded by the human gene MIR548, is a potential drug target and biomarker associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR548AR has been shown to play a crucial role in multiple cellular processes, including cell signaling, migration, and invasion, which has led to its potential as a drug target. In this article, we will discuss the biology and potential drug targets of MIR548AR, as well as its potential as a biomarker for disease diagnosis and progression.
The MIR548AR gene is located on chromosome 1p36 and encodes a protein with 548 amino acid residues. MIR548AR is a member of the T/YAM family, which includes other proteins involved in cell signaling and cytoskeletal organization. The T/YAM family is characterized by the presence of a T-loop and a Y/A-loop, which are conserved across various species and are involved in the regulation of protein stability and localization.
MIR548AR functions as a negative regulator of the T/YAM signaling pathway, which is a complex process involved in the regulation of cell signaling and cytoskeletal organization. The T/YAM signaling pathway is involved in various cellular processes, including cell growth, differentiation, and migration. MIR548AR has been shown to regulate the stability of the protein F-actin, which is involved in cell signaling and cytoskeletal organization.
In addition to its role in cell signaling and cytoskeletal organization, MIR548AR has also been shown to play a crucial role in the regulation of cell adhesion and migration. MIR548AR has been shown to regulate the adhesion of cancer cells to the extracellular matrix (6), and it has been implicated in the regulation of cancer cell migration and invasion.
MIR548AR has also been shown to be involved in the regulation of inflammation and autoimmune disorders. MIR548AR has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾, which are involved in the regulation of inflammation and autoimmune disorders.
In terms of its potential as a drug target, MIR548AR is an attractive target due to its involvement in multiple cellular processes that are involved in the regulation of cell signaling, cytoskeletal organization, cell adhesion, and inflammation. MIR548AR has been shown to be involved in the regulation of cell adhesion, migration, and invasion, which makes it an attractive target for the development of anti-cancer and anti-inflammatory drugs.
In terms of its potential as a biomarker, MIR548AR has been shown to be involved in the regulation of cell signaling and cytoskeletal organization, which makes it an attractive target for the development of biomarkers for disease diagnosis and progression. MIR548AR has been shown to regulate the production of pro-inflammatory cytokines, which makes it an attractive target for the development of biomarkers for inflammation-related diseases.
In conclusion, MIR548AR is a protein that has been shown to play a crucial role in multiple cellular processes, including cell signaling, migration, and invasion. Its potential as a drug target and biomarker makes it an attractive target for the development of new therapies for a variety of diseases. Further research is needed to fully understand the biology and potential drug targets of MIR548AR, as well as its potential as a biomarker for disease diagnosis and progression.
Protein Name: MicroRNA 548ar
The "MIR548AR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548AR comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR548AS | MIR548AT | MIR548AU | MIR548AV | MIR548AW | MIR548AX | MIR548AY | MIR548AZ | MIR548B | MIR548BA | MIR548BC | MIR548C | MIR548D1 | MIR548D2 | MIR548E | MIR548F1 | MIR548F2 | MIR548F3 | MIR548F4 | MIR548F5 | MIR548G | MIR548H1 | MIR548H2 | MIR548H3 | MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B
